De ce avem nevoie de mai multă Europa și de experți în domeniul sănătății? Înregistrați-vă acum: Evenimentul CAN.HEAL, Roma, 26-27 aprilie

Another day and a further EAPM despatch for your delight and delectation…and a reminder regarding the registration for our CAN.HEAL event taking place in Roma which ECPC and EAPM are organizing, scrie directorul executiv al Alianței Europene pentru Medicină Personalizată (EAPM), Denis Horgan.

But before all that, here is a shout out and a link to our recent academic publication that discusses the European Health Data Space which is entitled ‘Clouds across the new dawn for clinical, diagnostic and biological data: accelerating the development, delivery and uptake of personalized medicine".

The article argues that while health data is enjoying a new recognition with strong promises of a revolution in care – but crucial gaps must urgently be filled before any of the promises can become a reality. Above all, it is necessary to bring greater precision to the heady discussions about healthcare policy now sweeping across Europe, complementing rhetoric with clearer awareness of the mechanics of exploiting health data to boost healthcare delivery, research, innovation and policy making with safe and secure exchange, use and reuse. The aspiration may be noble in the EU presentation of its proposal for a regulation on health data as “a quantum leap” that it will “unleash the full potential” of data, but securing that goal is already proving more of a challenge than the expression of a vision.

Policymaking needs to be shifted towards more practical solutions, a rigorous assessment of the underlying realities, clearer objectives and mechanisms. Management of individual data has emerged from the development of art. 13 GDPR 679/16 “European regulation on the protection of personal data” . So efficient methods must be agreed to provide for confidentiality without impeding accepted use. Again, to overcome difficulties in feedback for data use and imple- mentation in healthcare, centres which analyse genomic data and return the info to submitting clinicians may offer a valuable route to transmit information also to the patient. The regulatory framework for this rapidly-advancing field will have to be so constructed that it can be adapted to respond to innovation, and the training needs right across the sector will have to be taken into account.

Legislators must recognize the scale of the challenges and the harsh lessons from recent issues in planning of healthcare policy making. Adequate provision must be foreseen for the scope of the challenges that will be faced as the legislation comes into effect – and as technology continues to evolve. The political process must also take account of the intensely practical economic aspects of the changes envisaged: funding will be required to meet the inevitable costs of creating systems able to do justice to the wealth of data that can be mobilized to improve patient safety.

More mature thinking can avoid this project falling victim to unintended consequences – the fate that has already befallen some legislation central to EU health policy which I am sure will be discussed in the Roma event which is entitled ‘Reducing Disparities Across the European Union’.

Vă rugăm să faceţi clic pe aici to registration for the event and to view the agenda, please click aici.

publicitate

Do all roads lead to Rome to reduce disparities in cancer, 26-27 April?

This event in Roma is intended to provide a compendium of evidence for the adoption of innovation in European healthcare, and to offer some suggestions on what changes are needed to make that possible quickly.

The event will draw on the work from the EU in cancer policy for more than two decades of pioneers in science and medicine, and of the more far-sighted politicians and officials.

At its heart is the question: "What is the framework to ensure that health innovation gets into EU healthcare systems at a faster pace?"

It will outline the context for policy formation in Europe, with an eye to the constant adaptation of the EU itself in its own membership and concerns, as it responds to internal pressures and to the shifting world around it. It makes the case that this ceaseless change can, if approached intelligently, be an opportunity for introducing new thinking more in tune with the future than the past. 

It will explore the EU's relationship with innovation and the new horizons opened up by IT, Big Data, and breakthroughs in the life sciences. It postulates that there is a growing recognition that whatever else the EU seeks to achieve, a mature approach to innovation is indispensable.

It will focus on the health policy context, reviewing the slow and still incomplete search for a coherent health policy in a European Union where national conditions vary so widely, and, crucially, where the very constitution of the EU itself presents challenges to attempts to establish common policies. It will make the case, however, for a 30,000 feet view which makes more apparent the strategic advantages of working together to take advantage of innovation.

It will tighten its focus on the potential of personalised medicine, pharmacogenomics and big data in healthcare. It spells out the progress made with the various EBCP projects that will drive forward European genomics, and the exciting work being done across the continent. And it reviews barriers to exploiting this potential, and highlights the urgency of action in an increasingly cross-border context for research and care. 

It will give particular attention to the role of the regions in bringing innovation into healthcare management, with only light-touch EU governance, in a framework that is founded on the trust essential to all healthcare systems.

We look forward to seeing you in Roma. 

Vă rugăm să faceţi clic pe aici to register for the event and to view the agenda please click aici.  As mentioned, the event is organized by the European Cancer Patient Coalition and EAPM. 

And to view our publication, please click here: ‘Clouds across the new dawn for clinical, diagnostic and biological data: accelerating the development, delivery and uptake of personalized medicine".

Trimiteți acest articol: